News

CN EN

Stock code: 002653.SZ

Home

News

Innovation

Pipeline R&D Platforms

Products

Product List Product Topics Pharmacovigilance

Investors

Stock Information Company Announcements Market Data Q&A Investor Hotline

Join Us

Talent Philosophy Careers

About Haisco

About Us Business Presence

GLOBAL

English China

All news Business News Announcement and Publicity

Business News

Xinhua Net: Haisco Technology Steps into the Top Tier of Innovation

Why is Cipepofol named 3486? How much is its efficacy increased by five times, and what clinical benefits does it bring? How did Haiscoo get its name? Where does the confidence of “in China, for the world” come from... On June 22, Xinhua Net published a in-depth report titled “Domestic anesthetic drugs ‘skip steps’ and receive FDA approval in the US; after fifteen years, Haiscoo enters the top tier of innovative drugs”. The full text is 2608 words. Now the original article is reprinted for readers.

Jun 26, 2026

Learn more

Business News

On June 1, 2026, China’s Class 1 intravenous anesthesia innovative drug cyclopentolate was approved for marketing by the US FDA.

2026-06-02

Learn more

Business News

2026.6.1 Hisicor and Eli Lilly reach their first collaboration, up to $3.054 billion.

2026-06-01

Learn more

Business News

2026.6.1 Wu Nan, Haisco: The Strong Competence Behind the US FDA’s “skip-stage approval” for cyclopelline

2026-06-01

Learn more

Business News

2026.5.12 Hisico launches two Phase III clinical trials for a new class of drug

2026-05-12

Learn more

Business News

2026.5.12 Haisco Innovation Medicine Kligabalin to be included in priority review

2026-05-12

Learn more

Business News

On May 12, 2026, the application for marketing authorization for the new indication of “postoperative pain” for Anruikefen Injection was accepted.

2026-05-12

Learn more

Business News

On May 11, 2026, Haisco has issued a notice regarding the 2026 “May 15 National Investor Protection Awareness Day” event.

2026-05-11

Learn more

Business News

April 27, 2026: Central media focus on the important research progress of Hisico’s innovative drug “Kligabalin”

2026-04-27

Learn more

Business News

On April 27, 2026, the International Pharmaceutical Science Exchange Conference hosted by Haisco is held in Shanghai to promote international exchanges and innovation.

2026-04-27

Learn more